Infinimmune
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
$75MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
Pitching Regeneron Ventures? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room